Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:WMA Declaration of Helsinki 2024 Paragraph 23 - Amendment approval  +
• Reference:ICH ICH E6 Guideline R3 (2025) GLOSSARY - Protocol Amendment  +
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 3.2 - Responsibility  +
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - Amendment  +
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Platform, basket and umbrella trials  +
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 7.5.1  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 2 Paragraph 13  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 15  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 16  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 17 Paragraph 1-3  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 17 Paragraph 4-5  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 18 Paragraph 1-3  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 19 Paragraph 1  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 19 Paragraph 2-4  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 20 Paragraph 1-3  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 20 Paragraph 4-7  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 21  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 22  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 23 Paragraph 1-2  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 23 Paragraph 3-6  +
• Reference:EU Regulation (EU) 536/2014 - clinical trials 05-Dec-2022 Article 24  +
• Reference:EU Regulation (EU) 2017/745 - Medical Device Regulation 20-Mar-2023 Article 75  +
• Reference:EU Regulation (EU) 2017/746 - in vitro diagnostic medical devices 20-Mar-2023 Article 71  +
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 40c-002  +
• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 8  +
• Reference:DEU KPBV - Klinische Prüfung-Bewertungsverfahren-Verordnung 31-Jan-2022 § 9  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 40  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 41  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 42  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 54  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 55  +
• Reference:DEU MPDG - Medizinprodukterecht-Durchführungsgesetz 28-Jun-2022 § 59  +
• Reference:DEU AMG - Arzneimittelgesetz 19-Jul-2023 § 63g (3)  +
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 2.4  +
• Reference:DEU DGEPi - GEP Guter Epidemiologischer Praxis Sep-2018 Leitlinie 6 6.3  +
• Reference:AUT BASG - FAQ 11-Feb-2025 Änderung am Personal  +
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 11  +
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 22-23  +
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 24  +
• Reference:GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 25  +
• Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.110 (b) (2)  +
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.30  +
• Reference:USA 21 CFR Part 312 09-Apr-2025 § 312.31  +
• Reference:USA 21 CFR Part 812 09-Apr-2025 § 812.35  +